Winston's Hurst Scores for Generics at Supreme Court

News | 01 January 2013

• Print This

Tuesday's ruling for Caraco Pharmaceutical Laboratories against Novo Nordisk makes it easier for generics to bring successful counterclaims against brand-name drug companies in Hatch-Waxman Act litigation--and ultimately to get their own drugs on the ...

Click on the link to read the full article at The American Lawyer
(This link will open in a new window)